אומניפאק 300
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
IOHEXOL
Disponibbli minn:
ELDAN ELECTRONIC INSTRUMENTS CO LTD
Kodiċi ATC:
V08AB02
Għamla farmaċewtika:
תמיסה להזרקה
Kompożizzjoni:
IOHEXOL 647 MG/ML
Rotta amministrattiva:
תוך-ורידי
Tip ta 'preskrizzjoni:
מרשם נדרש
Manifatturat minn:
GE HEALTHCARE AS, NORWAY
Grupp terapewtiku:
IOHEXOL
Żona terapewtika:
IOHEXOL
Indikazzjonijiet terapewtiċi:
X-ray contrast medium for use in adults and children for cardioangiography, arteriography, urography, phlebography and CT- enhancement. Lumbar, thoracic, cervical myelography and computed tomography of the basal cisterns, following subarachnoid injection. Arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography, sialography and studies of the gastrointestinal tract.
Data ta 'l-awtorizzazzjoni:
2021-04-30
